共 50 条
- [1] Phase I, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous, Dose-Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (10): : 2661 - 2671
- [2] Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study [J]. LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
- [7] Bromocriptine in systemic lupus erythematosus: A double-blind, randomized placebo-controlled study. [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1351 - 1351
- [8] A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1168 - 1178